Subscribe To
Halozyme (halo) inks collaboration deal with chugai pharma
Halozyme (HALO) and Japan-based Chugai pharma sign a collaboration agreement, which gives the latter an...
March 25, 2022, 11:17 am
This pharma stock's luck may be changing, says analyst
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) stock was last seen up 4.7% at $8.55 this morning, following an upgrade from Bernstein....
March 25, 2022, 9:49 am
Why mei pharma stock is plummeting after hours
MEI Pharma Inc (NASDAQ: MEIP) shares are plunging in Thursday's after-hours session after the company provided an investor update following a recent ...
March 24, 2022, 4:51 pm
Innate pharma s.a. (ipha) ceo mondher mahjoubi on q4 2021 results - earnings call transcript
Innate pharma s.A. (IPHA) CEO Mondher Mahjoubi on Q4 2021 Results - Earnings Call Transcript...
March 24, 2022, 2:35 pm
Should you buy this big pharma stock?
AstraZeneca possesses a stacked, commercialized drug portfolio. And its pipeline of drug candidates is just as enviable....
March 24, 2022, 11:30 am
4d pharma shares soar on mrx0518/keytruda combo trial data in renal cell carcinoma
4D pharma plc (NASDAQ: LBPS) has announced interim results from Phase 1/2 study evaluating the combination of MRx0518 and Merck & Co Inc's (NYSE:...
March 23, 2022, 9:43 am
4d pharma sees early success as phase i/ii cancer trial hits its efficacy target early
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) said it had hit its primary efficacy target in a phase I/II trial of one of its lead assets in kidney cancer. MR...
March 23, 2022, 3:56 am
Valeo pharma secures public reimbursement for redesca and redesca hp in british columbia
Valeo Pharma Inc said it has successfully entered into a Product Listing Agreement (PLA) with the British Columbia Minister of Health for the listing ...
March 22, 2022, 9:15 am
Why are allena pharma shares plunging today
An independent data safety monitoring board (DSMB) has conducted the first of two planned Sample Size Reestimations (SSR1) of Phase 3 URIROX-2 Trial�...
March 21, 2022, 9:48 am
Hc wainwright sees almost 1000% upside on spectrum pharma stock
HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues...
March 18, 2022, 2:08 pm
Betterlife pharma says preclinical data has confirmed bioavailability of betr-001
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) announced it had confirmed the bioavailability of its lead compound BETR-001 in the brain tissue and pla...
March 16, 2022, 4:57 pm
Nls pharma shares fall after mazindol er interim data shows 39% improvement on sleepiness scale
NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol ...
March 16, 2022, 2:06 pm
Erytech pharma s.a. (eryp) ceo gil beyen on q4 2021 results - earnings call transcript
ERYTECH pharma s.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript...
March 14, 2022, 1:33 pm
Seagen: long-term pharma stock to own based on sales growth and oncology portfolio
Seagen: Long-Term pharma stock To Own Based On Sales Growth And Oncology Portfolio...
March 12, 2022, 2:33 am
Sbfm stock alert: 7 things to know as sunshine biopharma skyrockets
Today, investors in Sunshine Biopharma and SBFM stock are seeing impressive gains. The stock is surging more than 160% on intense interest....
March 9, 2022, 3:08 pm
Truist sees 350% upside on this cancer-focused biopharma stock - read why
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% up...
March 9, 2022, 12:56 pm
3 biopharma stocks that analysts have grown bearish on
The S&P 500, Nasdaq and Dow Jones industrial average have all entered correction territory within the past month, and investors took the brunt of this...
March 1, 2022, 6:48 am
3 biopharma stocks that analysts have grown bearish on
The S&P 500, Nasdaq and Dow Jones industrial average have all entered correction territory within the past month, and investors took the brunt of this...
March 1, 2022, 6:48 am
3 biopharma stocks that analysts have grown bearish on
The S&P 500, Nasdaq and Dow Jones industrial average have all entered correction territory within the past month, and investors took the brunt of this...
March 1, 2022, 6:48 am
Dow jones newswires: atea pharma stock jumps as earnings rise, potential covid-19 therapy advances
Shares of Atea Pharmaceuticals Inc. were trading over 18% higher in the after-hours market Monday, following the company's release of fourth-quarter f...
February 28, 2022, 6:40 pm